Car­lyle’s Abing­worth will help fund Te­va’s Phase 3 asth­ma res­cue in­haler

Abing­worth will pro­vide up to $150 mil­lion to help fund Te­va Phar­ma­ceu­ti­cals’ de­vel­op­ment of an asth­ma res­cue in­haler, the com­pa­nies said Mon­day morn­ing.

The as­set …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER